Cost-Effectiveness and Cost–Utility Analysis of the Use of Clopidogrel and Pantoprazole in Comparison with Clopidogrel and Omeprazole for the Secondary Prevention of Myocardial Infarction in Iran

OBJECTIVE: Gastrointestinal bleeding, a side effect of clopidogrel, is usually prevented by proton-pump inhibitors (PPIs). Due to omeprazole's inhibitory effects on the liver enzyme CYP2C19, its concomitant use with clopidogrel is argued to increase the risk of myocardial infarction (MI) recurr...

Descripción completa

Detalles Bibliográficos
Autores principales: Amirsadri, Mohammadreza, Hajhashemi, Valiollah, Asemi, Amir Shahriar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420933/
https://www.ncbi.nlm.nih.gov/pubmed/34527614
http://dx.doi.org/10.4103/jrpp.JRPP_21_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420933/
https://www.ncbi.nlm.nih.gov/pubmed/34527614
http://dx.doi.org/10.4103/jrpp.JRPP_21_22

Ejemplares similares